VTRS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
VTRS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Viatris's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2023 was $-2,747 Mil.
Viatris's quarterly Accumulated other comprehensive income (loss) declined from Jun. 2023 ($-3,006 Mil) to Sep. 2023 ($-3,209 Mil) but then increased from Sep. 2023 ($-3,209 Mil) to Dec. 2023 ($-2,747 Mil).
Viatris's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 ($-1,744 Mil) to Dec. 2022 ($-2,761 Mil) but then increased from Dec. 2022 ($-2,761 Mil) to Dec. 2023 ($-2,747 Mil).
The historical data trend for Viatris's Accumulated other comprehensive income (loss) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viatris Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Accumulated other comprehensive income (loss) | Get a 7-Day Free Trial | -1,797.20 | -858.00 | -1,744.30 | -2,761.20 | -2,747.40 |
Viatris Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Accumulated other comprehensive income (loss) | Get a 7-Day Free Trial | -2,761.20 | -2,764.60 | -3,005.60 | -3,208.50 | -2,747.40 |
Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.
Thank you for viewing the detailed overview of Viatris's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.
Andrew Cuneo | officer: See Remarks | 1000 MYLAN BOULEVARD, CANONSBURG PA 15317 |
Xiangyang (sean) Ni | officer: President, Greater China | 1000 MYLAN BOULEVARD, CANONSBURG PA 15317 |
Leo Frans Groothuis | director | 1000 MYLAN BOULEVARD, CANONSBURG PA 15317 |
Scott Andrew Smith | director | C/O CELGENE CORPORATION, 86 MORRIS AVENUE, SUMMIT NJ 07901 |
Elisha W Finney | director | C/O VARIAN MEDICAL SYSTEMS, INC, 3100 HANSEN WAY M/S E-327, PALO ALTO CA 94304 |
Van Der Meer Mohr Pauline | director | 1000 MYLAN BOULEVARD, CANONSBURG PA 15317 |
Menassie Taddese | officer: See Remarks | 1000 MYLAN BOULEVARD, CANONSBURG PA 15317 |
Robert J Coury | director, officer: Executive Chairman | BUILDING 4, TRIDENT PLACE, MOSQUITO WAY, HATFIELD, HERTFORDSHIRE X0 AL10 9UL |
W Don Cornwell | director | |
Brian Roman | officer: Global General Counsel | 1000 MYLAN BOULEVARD, CANONSBURG PA 15317 |
Anthony Mauro | officer: See Remarks | BUILDING 4, TRIDENT PLACE, MOSQUITO WAY, HATFIELD, HERTFORDSHIRE X0 AL10 9UL |
James M Kilts | director | 120 PARK AVE, NEW YORK NY 10017 |
Melina E Higgins | director | BUILDING 4, TRIDENT PLACE, MOSQUITO WAY, HATFIELD, HERTFORDSHIRE X0 AL10 9UL |
Ian C Read | director | PFIZER INC ATTN CORPORATE SECRETARY, 235 EAST 42ND STREET, NEW YORK NY 10017 |
Dillon Joellen Lyons | director | BUILDING 4, TRIDENT PLACE, MOSQUITO WAY, HATFIELD, HARTFORDSHIRE X0 AL 109UL |
From GuruFocus
By GuruFocus Research • 09-06-2023
By PRNewswire • 11-14-2023
By PRNewswire • 10-23-2023
By ACCESSWIRE • 09-13-2023
By PRNewswire • 10-01-2023
By PRNewswire • 10-30-2023
By GuruFocus Research • 09-06-2023
By ACCESSWIRE • 10-26-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.